Title: McIlvaine Insights Issue 184, December 16, 2021

• Blood Plasma Fractionation as an Example of a Path to Greater Profits for Air, Water and Energy (AWE) Suppliers • $10 billion for High Performance AWE Product LTCOV will be Justified

Click Here For Complete Insights Text

 

   Person Information
   Application Sequencing
                  
 541711 - Research and Development in Biotechnology                
Company  Product  Process  Other  Subjects  Event  Event  Date  Location  Publication  Publication  Date Text  Descriptor
  • McIlvaine

  • Contamination Control

 

  • Supplier

 

 

 

  • McIlvaine Insights

 

  • 12/16/2021

 

  • Insights